CTF in the NewsScience & Research Repurposed Drugs Offer Hope and Momentum for Rare Disease Treatments
Awards & GrantsFeaturedFeatured EUScience & Research Attention NF Researchers: New Federal Funding Opportunities Available
CTF in the NewsFeaturedFeatured EUScience & Research CTF Featured in Clinical Research News for Rethinking the Role of Nonprofits in R&D
FeaturedFeatured EUScience & Research CTF CEO Annette Bakker Moderates Panel at World Orphan Drug Congress 2025
CTF in the NewsFeaturedFeatured EUScience & Research How a Once-Abandoned Drug Found New Life – and Changed the Future for NF Patients
Awards & GrantsFeaturedFeatured EUNF1Science & Research Young Investigator: Q&A with Sarah Morrow about NF1 and MPNST
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaPress ReleaseScience & Research Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of NF1
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaPress ReleaseScience & Research CureAge Therapeutics Launches to Advance Genetic Therapies for Neurofibromatosis
Science & Research NF Science Explained: Research Links Immune Cells to Tumor Growth in Vestibular Schwannomas